Cargando…
COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury
Light chain (AL) amyloidosis is a potentially fatal disease of monoclonal plasma cells that leads to accumulation of light chain amyloid fibrils, organ damage, and the manifestations of clinical disease. Meanwhile, coronavirus disease 2019 (COVID-19) is a disease caused by infection with the severe...
Autores principales: | Crees, Zachary D., Stockerl-Goldstein, Keith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783834/ https://www.ncbi.nlm.nih.gov/pubmed/35081378 http://dx.doi.org/10.1016/j.amjmed.2022.01.005 |
Ejemplares similares
-
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
por: Zhang, Kathleen W., et al.
Publicado: (2019) -
COVID-19-associated pulmonary aspergillosis: adding insult to injury
por: Bruno, Giuseppe, et al.
Publicado: (2020) -
Antibiotic Overuse for COVID-19: Are We Adding Insult to Injury?
por: Abdela, Seid Getahun, et al.
Publicado: (2021) -
How to Screen for Monoclonal Gammopathy in Patients With a Suspected Amyloidosis
por: Rubinstein, Samuel M., et al.
Publicado: (2021) -
Adding Insult to Injury: The COVID‐19 Crisis Strikes Latin America
por: Grigera, Juan
Publicado: (2022)